Home
About CytoDyn
Overview
Our Mission
Our Science
Pipeline
Our Team
Leadership Team
Scientific Advisory Board
Board of Directors
Join our Team
Publications & Posters
Newsroom
Press Releases
Investors
Overview
Investor FAQs
Investor Update Calls
Annual Meeting of Stockholders
Warrant Exercise Inquiries
Restricted Stock Inquiries
News / Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact
All SEC Filings
Investors
Investors
Overview
Investor FAQs
Investor Update Calls
Annual Meeting of Stockholders
Warrant Exercise Inquiries
Restricted Stock Inquiries
News / Events
Overview
Press Releases
In The News
IR Calendar
Email Alerts
Company Info
Overview
Leadership Team
Presentations
Contacts
Company FAQs
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
10SB12G
15-12G
3
3/A
4
4/A
424B2
424B3
424B5
424B7
425
5
8-K
8-K/A
8-K12G3
ARS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFC14A
DFAN14A
DFRN14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PRER14A
PRRN14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Date
Form
Description
PDF
XBRL
Pages
01/25/22
8-K
Current report filing
3
01/10/22
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-3.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
95
01/05/22
8-K
Current report filing
4
Previous
2
3
4
5
6
7
8
9
10
11
Email Alerts
Contacts
RSS News Feed
